279 related articles for article (PubMed ID: 36068461)
21. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
Wiltshire T; Dong OM
Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy.
Fujita K; Sasaki Y
Curr Drug Metab; 2007 Aug; 8(6):554-62. PubMed ID: 17691917
[TBL] [Abstract][Full Text] [Related]
23. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
Brandl E; Halford Z; Clark MD; Herndon C
Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics in cancer therapy: is host genome variability important?
Petros WP; Evans WE
Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer.
Talebi Z; Sparreboom A; Colace SI
Methods Mol Biol; 2022; 2547():47-61. PubMed ID: 36068460
[TBL] [Abstract][Full Text] [Related]
27. Integrating Pharmacogenetic Decision Support into a Clinical Information System.
Tippenhauer K; Philips M; Largiadèr CR; Sariyar M; Bürkle T
Stud Health Technol Inform; 2020 Jun; 270():618-622. PubMed ID: 32570457
[TBL] [Abstract][Full Text] [Related]
28. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
30. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
Robert J
J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
[TBL] [Abstract][Full Text] [Related]
32. Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing?
Tilleman L; Heindryckx B; Deforce D; Van Nieuwerburgh F
Pharmacogenomics; 2020 Oct; 21(15):1073-1084. PubMed ID: 33019866
[No Abstract] [Full Text] [Related]
33. Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.
Pozdeyev N; Yoo M; Mackie R; Schweppe RE; Tan AC; Haugen BR
Oncotarget; 2016 Aug; 7(32):51619-51625. PubMed ID: 27322211
[TBL] [Abstract][Full Text] [Related]
34. Evolving Role of Pharmacogenetic Biomarkers to Predict Drug-Induced Hematological Disorders.
Pattanaik S; Jain A; Ahluwalia J
Ther Drug Monit; 2021 Apr; 43(2):201-220. PubMed ID: 33235023
[TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacogenomics of antiretroviral and cytotoxic treatments.
Stebbing J; Bower M
Lancet Oncol; 2006 Jan; 7(1):61-8. PubMed ID: 16389185
[TBL] [Abstract][Full Text] [Related]
36. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics of neoplastic diseases: new trends.
Di Paolo A; Danesi R; Del Tacca M
Pharmacol Res; 2004 Apr; 49(4):331-42. PubMed ID: 15202512
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity.
Chang VY; Wang JJ
Curr Oncol Rep; 2018 Apr; 20(7):52. PubMed ID: 29713898
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
Lee SY; McLeod HL
J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
Donnelly JG
Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
